Treatment of mycobacterial pulmonary diseases is challenged by long treatment durations and severe systemic toxicities of antibiotics such as oxazolidinones. Here, we developed an inhalable nanohybrid of delpazolid (DZD), termed DZD@DLC (a composite didodecyld... ...

请注册登录后继续浏览